130 related articles for article (PubMed ID: 38734152)
1. Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
Canet G; Gratuze M; Zussy C; Bouali ML; Diaz SD; Rocaboy E; Laliberté F; El Khoury NB; Tremblay C; Morin F; Calon F; Hébert SS; Julien C; Planel E
Neurobiol Dis; 2024 Aug; 198():106526. PubMed ID: 38734152
[TBL] [Abstract][Full Text] [Related]
2. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.
Li Y; Duffy KB; Ottinger MA; Ray B; Bailey JA; Holloway HW; Tweedie D; Perry T; Mattson MP; Kapogiannis D; Sambamurti K; Lahiri DK; Greig NH
J Alzheimers Dis; 2010; 19(4):1205-19. PubMed ID: 20308787
[TBL] [Abstract][Full Text] [Related]
4. Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer's Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation.
Zhou C; Jung CG; Kim MJ; Watanabe A; Abdelhamid M; Taslima F; Michikawa M
Mol Neurobiol; 2022 Sep; 59(9):5408-5425. PubMed ID: 35701718
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
6. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
Tran HT; LaFerla FM; Holtzman DM; Brody DL
J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
[TBL] [Abstract][Full Text] [Related]
7. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
[TBL] [Abstract][Full Text] [Related]
8. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
9. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
[TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice.
Chen Y; Liang Z; Tian Z; Blanchard J; Dai CL; Chalbot S; Iqbal K; Liu F; Gong CX
Mol Neurobiol; 2014 Feb; 49(1):547-62. PubMed ID: 23996345
[TBL] [Abstract][Full Text] [Related]
11. Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.
Latina V; Giacovazzo G; Calissano P; Atlante A; La Regina F; Malerba F; Dell'Aquila M; Stigliano E; Balzamino BO; Micera A; Coccurello R; Amadoro G
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830036
[TBL] [Abstract][Full Text] [Related]
12. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms.
Planel E; Tatebayashi Y; Miyasaka T; Liu L; Wang L; Herman M; Yu WH; Luchsinger JA; Wadzinski B; Duff KE; Takashima A
J Neurosci; 2007 Dec; 27(50):13635-48. PubMed ID: 18077675
[TBL] [Abstract][Full Text] [Related]
13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
15. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
[TBL] [Abstract][Full Text] [Related]
16. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
[TBL] [Abstract][Full Text] [Related]
18. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
[TBL] [Abstract][Full Text] [Related]
20. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
Joshi YB; Chu J; Praticò D
Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]